Skip to content
Peptigraph home

CJC-1295 + Ipamorelin for Muscle Growth: What the Evidence Shows

What human and animal studies show about CJC-1295 + Ipamorelin for muscle growth, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGHRH + GHRP blendUpdated
Strongest evidence
Human observational
from an ingredient's studies
Human studies
1
PubMed records, our ledger
Animal studies
0
PubMed records, our ledger
Studies we summarised
6
with an outcome for muscle growth

Evidence for muscle growth

Each row is an outcome related to muscle growth from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here. No study has tested CJC-1295 + Ipamorelin itself; rows are for each ingredient.

CJC-1295 + Ipamorelin for muscle growth: outcomes in published studies
OutcomeResultStudy typeSource
CJC-1295: Reasons for use reported on forumsForum users cited weight loss, muscle enhancement, youthful skin, improved sleep and injury healing as reasons for use; these are user-stated motives, not measured results.Human observationalSubstance use & misuse 2016, PMID 26771670
CJC-1295: Regulatory status and evidence for physique claimsThe review notes no regulatory approval for physique- or performance-related indications of these peptides, including this long-acting GHRH analog.ReviewFrontiers in endocrinology 2026, PMID 42395176
Ipamorelin: Regulatory status and evidence for physique claimsThe review notes no regulatory approval for physique- or performance-related indications of these peptides, including ipamorelin.ReviewFrontiers in endocrinology 2026, PMID 42395176
Ipamorelin: Muscle strength and bone formation under glucocorticoidAdding ipamorelin to glucocorticoid increased calf-muscle tetanic tension and raised periosteal bone formation four-fold versus glucocorticoid alone.Animal · rat (not a human result)Growth hormone & IGF research 2001, PMID 11735244
Ipamorelin: Body weight and bone mineral contentIpamorelin, another GHRP and GH all increased body weight and bone mineral content versus vehicle; BMC per body weight was unchanged.Animal · rat (not a human result)The Journal of endocrinology 2000, PMID 10828840
Ipamorelin: Bone growth and body weightLongitudinal bone growth rose dose-dependently from 42 microm/day (vehicle) to 44, 50 and 52 microm/day, with dose-dependent body weight gain.Animal · rat (not a human result)Growth hormone & IGF research 1999, PMID 10373343

PubMed records for CJC-1295 + Ipamorelin and muscle growth: 1 human, 0 animal (search counts, not studies we reviewed). Grades follow our .

How strong is it?

Strongest evidence:Human observational evidence, 3 of 4CJC-1295: Substance use & misuse 2016, PMID 26771670

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

What "muscle growth" means here

MedlinePlus describes strength or resistance training as exercise that uses weights, bands or body weight to build stronger muscles.[6]

What has been studied for the CJC-1295 plus ipamorelin pairing

A PubMed search requiring CJC-1295, ipamorelin and a muscle-mass term (run 2 Oct 2026) returned 1 record in total: 1 human record and 0 animal records.

Calculated from human 1; animal 0; all 1. Formula: Counts copied from the cjc-1295-ipamorelin ledger row for the muscle-growth goal in goals.json; no arithmetic.

A narrative review sorts GH-axis peptides into evidence tiers, from regulatory-grade randomized trial data to a complete absence of human studies, and highlights the resulting uncertainty around putative performance and recomposition benefits.[2]

What each half has been measured doing

In healthy adults, a single CJC-1295 injection raised mean growth hormone 2- to 10-fold and IGF-I 1.5- to 3-fold. These are hormone levels, not muscle measurements.[7]

The one ipamorelin trial in people cited here tested it after bowel surgery and found no significant difference from placebo in its efficacy analyses. Muscle was not its question.[8]

In a rat study, ipamorelin produced a pronounced, dose-dependent effect on body weight gain. This is rat data, not human muscle.[5]

Adverse effects documented for this class

A review of self-administered GH-axis peptides reports adverse effects including prolactin and cortisol elevations, appetite changes, dysglycaemia, fluid retention, myalgia/arthralgia and injection-site reactions.[2]

Other peptides people research for muscle growth

All peptides for muscle growth, compared

Common questions

Does CJC-1295 + Ipamorelin help with muscle growth?

The strongest study we summarise for muscle growth is human observational evidence, for an ingredient rather than the blend, across 6 studies with an outcome for muscle growth. That is not proof it works in people.

Is CJC-1295 + Ipamorelin approved for muscle growth?

No. CJC-1295 + Ipamorelin is not FDA approved for any use, including muscle growth.

What is the best peptide for muscle growth?

There is no single answer. Our muscle growth overview compares each candidate by evidence grade and legal status rather than by popularity.

Does CJC-1295 with ipamorelin build muscle?

The review that grades GH-axis peptide evidence highlights uncertainty around putative performance and recomposition benefits for this class.[2]

Is there a muscle-gain trial of CJC-1295 on its own?

The cached CJC-1295 trial reports sustained, dose-dependent GH and IGF-I increases in healthy adults. Those are hormone levels, not muscle outcomes.[7]

More on CJC-1295 + Ipamorelin

Sources

  1. 1Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.Substance use & misuse · 2016PMID 26771670Accessed 2 Oct 2026
  2. 2The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Frontiers in endocrinology · 2026PMID 42395176Accessed 2 Oct 2026
  3. 3The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2001PMID 11735244Accessed 2 Oct 2026
  4. 4The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats.The Journal of endocrinology · 2000PMID 10828840Accessed 2 Oct 2026
  5. 5Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 1999PMID 10373343Accessed 2 Oct 2026
  6. 6Official web pageOfficial web page · web page
  7. 7Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.The Journal of clinical endocrinology and metabolism · 2006PMID 16352683Accessed 2 Oct 2026
  8. 8Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.International journal of colorectal disease · 2014PMID 25331030Accessed 2 Oct 2026

Found an error? Report a correction.